news

a-shares continued to fluctuate in a narrow range this morning, and the main indexes did not fluctuate much.

in terms of industry sectors and tracks, the communications equipment sector led the gains.

kweichow moutai's stock price continued to fall during the session, falling below the 1,300 yuan mark at one point. if calculated based on the historical highest price since 2021, kweichow moutai's stock price has almost been "cut in half" during this period.

today, a new stock was listed on the a-share market, china herbal flavors & fragrances. the stock's intraday increase once exceeded 300% in the morning trading.

kweichow moutai's share price fell below the 1,300 yuan mark, and its share price was almost "halved" from its historical high

the a-share market continued to fluctuate within a narrow range this morning, with major indexes not fluctuating much.

in terms of industry sectors and tracks, the communications equipment sector led the gains, with the sector's intraday increase exceeding 2%. datang telecom hit the daily limit during the session, and stocks such as dekeli and xinyisheng rose sharply during the session.

real estate, insurance, oil and other sectors also ranked among the top in intraday gains.

public transportation, brewing, electrical equipment, software services and other sectors saw the largest declines.

in terms of concept sectors, sand control, scarce resources and other concept sectors led the gains.

in terms of the performance of large-cap stocks, some stocks fell further during the session.

kweichow moutai's stock price continued to fall during the trading session, once falling below the 1,300 yuan mark. if calculated based on the unadjusted stock price, the above intraday low price hit a new low in the past four years. if adjusted for rights, the above intraday low stock price is also close to a two-year low. in addition, if calculated based on the historical highest price since 2021, kweichow moutai's stock price has almost been "cut in half."

the share price of another leading liquor stock, wuliangye, also declined, with an intraday drop of more than 2%.

the intraday decline of catl, the leading power battery company, once exceeded 2%.

the new stock zhongcao fragrance rose by more than 300% in the morning trading.

today, a new stock was listed on the a-share market, china herbal flavors & fragrances. the stock's intraday increase once exceeded 300% in the morning trading.

according to the prospectus, since its establishment, zhongcao flavors has focused on the research and development, production and sales of flavors and fragrances. the company's main products include cooling agents, synthetic flavors and natural flavors. among them, cooling agent products mainly include ws-23, ws-3, menthyl lactate, etc., synthetic flavors mainly include dibutyl ester, ethyl butyrate, etc., and natural flavors mainly include spearmint oil, garlic oil, ginger oil, red tangerine oil, etc. the company's products can be used in food and beverage, daily chemicals, tobacco, medicine and other industries, with a wide range of downstream applications and development space.

the company is a national high-tech enterprise and a specialized and innovative small and medium-sized enterprise in anhui province. it has a provincially certified enterprise technology center, anhui natural flavor extraction engineering technology research center, and a postdoctoral research workstation (postdoctoral innovation practice base). it has won the honorary titles of "provincial agricultural industrialization leading enterprise", "anhui top ten excellent brand enterprises", anhui enterprise r&d center, "anhui patent excellence award", "anhui labor and social security integrity demonstration unit", and "food safety anhui brand". the company's main product n,2,3-trimethyl-2-isopropylbutanamide (ws-23) has won the title of "anhui industrial boutique". as of the date of signing of the prospectus, the company has 10 invention patents and 5 design patents.

according to the prospectus, the company strictly implements product quality and environmental management control, and has passed iso9001:2005 quality management system certification, iso14001:2015 environmental management system certification, iso22000:2018 certification, kosher certification, fssc22000 certification, halal certification, eu reach registration, us fda certification, etc. after more than ten years of technology accumulation and market development, the company has accumulated high-quality and stable customer channels and resources, and established stable cooperative relations with the world's top ten flavor and fragrance companies such as symrise and givaudan.

hong kong stocks rose, and immuneonco's intraday increase was close to 60%

the hong kong stock market strengthened significantly this morning, with the hang seng index rising more than 1% during the session.

among the hang seng index constituents, many stocks such as sinopharm holdings rose by more than 5% during the trading session.

among the stocks whose share prices fluctuated sharply in the hong kong stock market, immune onco-b soared, with its intraday increase once approaching 60%.

immuneonco recently announced that it had received further payments under the authorization and cooperation agreement with synbiotx for imm2510 and imm27m. the announcement stated that the company's board of directors announced that the company had received a recent payment of us$5 million from synbiotx under the authorization and cooperation agreement. as of the date of the above announcement, the company had received a total of us$15 million in initial payments and recent payments under the authorization and cooperation agreement. according to the authorization and cooperation agreement, the company expects to receive a remaining potential recent payment of no more than us$35 million in the future.

the announcement stated that imm2510 was independently developed by the group and is a bispecific molecule targeting vascular endothelial growth factor (vegf) and programmed cell death ligand 1 (pd-l1), using a monoclonal antibody-receptor recombinant protein (mab-trap) structure. imm2510 can inhibit angiogenesis, shrink tumors, and make tumor cells more sensitive to immune responses. at the same time, it activates t cells, natural killer cells and macrophages by blocking the pd-l1/programmed cell death protein 1 (pd-1) interaction and inducing fc-mediated antibody-dependent cellular cytotoxicity (adcc)/antibody-dependent cellular phagocytosis (adcp) activity.

imm27m is a new generation of cytotoxic t lymphocyte-associated protein 4 (ctla-4) antibody with enhanced adcc activity. it can induce a strong immune response targeting ctla-4 overexpressed, immunosuppressive regulatory t cells, promote the clearance of regulatory t cells from the tumor microenvironment (tme), and thus enhance the anti-tumor response of t cells.

synbiotx inc. is a company incorporated in delaware, u.s. on july 30, 2024. it is a wholly-owned subsidiary of instilbio, inc., and is primarily engaged in clinical research and development. instilbio, inc. is a company incorporated in 2018, headquartered in dallas, texas, and listed on the nasdaq global market (nasdaq: til). the company is a clinical-stage biopharmaceutical company focused on developing novel therapeutics.

source: securities times